Affiliation:
1. 1From the Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
Abstract
There is concern that growth hormone (GH) therapy may influence the growth of melanocytic nevi. In a review of the experience of the National Cooperative Growth Study, we found no excess of skin cancer in children who were treated with GH. We also reviewed our experience in 90 children with GH deficiency and 24 with Turner syndrome. We found no difference in the nevi count between control subjects and children with GH deficiency, even after many years of GH therapy. Nor was there any relation between the duration of therapy and the nevi count. Children with Turner syndrome had more nevi, but there was no relation to the duration of GH therapy. These findings and the absence of a greater frequency of skin cancer in acromegaly are reassuring. It is unlikely that GH therapy has a significant influence on nevi count or the risk of skin cancer.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Reference24 articles.
1. Effects of human growth hormone therapy on melanocytic naevi.;Bourguignon;Lancet.,1993
2. Safety of recombinant deoxyribonucleic acid-derived growth hormone: the National Cooperative Growth Study experience.;Blethen;J Clin Endocrinol Metab.,1996
3. Safety of human growth hormone therapy: current topics.;Allen;J Pediatr.,1996
4. Benign melanocytic naevi as a risk factor for malignant melanoma.;Swerdlow;Br J Med.,1986
5. Mortality and cancer incidence in acromegaly: a retrospective cohort study.;Orme;J Clin Endocrinol Metab.,1998
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献